This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks Close Higher on U.S. Home Sales, Prospects for Central Bank Easing

NEW YORK ( TheStreet) -- U.S. stock markets gained Monday led by health care stocks after a report showed an improvement in home contract signings, a positive sign on national housing demand and economic momentum.

The S&P 500 added 0.7% to close at 1,593.60 while the S&P Healthcare Facilities Index was surging 6.8%.

The National Association of Realtors reported Monday that home contract signings rose to a five-year high in March excluding a surge related to the home-buyer tax credit. The index gained 1.5% last month after falling by a downwardly-revised decline of 1% in February. Economists, on average, were expecting a gain of 1%, according to a Thomson Reuters survey.

"The March pending sales reading likely points to a pick-up in existing home sales in April following a somewhat softer pace of home-buying activity at the start of the year," Yelena Shulyatyeva, an economist at BNP Paribas in New York, said in a client note.

Tenet Healthcare Corp. (THC - Get Report) jumped 6.5% to $43.84 after Robert Bairdand UBS raised their ratings to buy or an equivalent. Robert Baird analysts gave the health care company a 12-month price target of $51 on grounds that its Medicare reimbursement rates should rise. UBS noted that the Centers for Medicare and Medicaid Services-proposed Medicare net IPPS was better than expected.

Moody's (MCO - Get Report) surged 8.3% to $59.69 after the Associated Press reported over the weekend that it had settled a lawsuit with McGraw-Hill Companies' (MHP) Standard & Poor's unit and Morgan Stanley (MS - Get Report) dating back to the financial crisis. McGraw-Hill was advancing 2.8% to $53.45 and Morgan Stanley was up 3.8% to $22.21.

Markets also appeared buoyed by indications central banks around the world will continue implementing measures to stimulate their respective economies as the Bureau of Economic Analysis reported that the core PCE price index dropped to 1.1% year-over-year in March after being unchanged on a monthly basis as personal spending ticked up 0.2% in March and personal income rose 0.2%.

"The overall picture is the same--inflation has been steadily decelerating over the past year. This will be noticed and discussed at length at this week's FOMC meeting and will keep the Fed committed to expansionary policy," noted Julia Coronado, chief economist for North America at BNP Paribas in New York.

The U.S. Federal Reserve is scheduled to make an announcement following its two-day policy meeting that ends on Wednesday while the European Central Bank is expected to do the same on Thursday. UBS Economics estimates that the ECB's Governing Council will likely to cut its benchmark refinance rate by 25 basis points to 0.5%.

--Written by Andrea Tse in New York

>To contact the writer of this article, click here: Andrea Tse.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MCO $103.43 0.30%
MS $35.27 2.80%
THC $34.94 5.30%
AAPL $117.29 -0.85%
FB $107.04 2.70%


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs